Clinical Trials Directory

Trials / Completed

CompletedNCT03612583

Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
23 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to test a proposed strategy for lung- and diaphragm-protective ventilation (LDPV) in patients with acute hypoxemic respiratory failure. Ventilation and sedation will be titrated to evaluate whether it is feasible and safe within this patient population.

Detailed description

Lung injury and diaphragm injury incurred by mechanical ventilation have very serious adverse effects on patients with acute respiratory failure. Lung injury results from excessive mechanical stress and strain applied to the lung by the ventilator and/or respiratory muscles, while diaphragm injury results from either insufficient or excessive inspiratory effort. The objective of this study is to investigate a new LDPV strategy designed to prevent both disuse-mediated and load-induced diaphragm injury, while also preventing excess global and regional mechanical stress and strain in the injured lung. To achieve these goals, the following specific targets to be met are: (1) respiratory muscle effort similar to that of healthy subjects breathing at rest, (2) lung stress within safe limits, and (3) clinically acceptable gas exchange. Targets are assessed through measurements of global lung stress, tidal recruitment, inspiratory effort, diaphragm contractile effort and adequacy of respiratory muscle and systemic tissue perfusion. Measurements commence at enrollment and continue for 24 hours consecutively.

Conditions

Interventions

TypeNameDescription
PROCEDURELung- and Diaphragm-Protective VentilationVentilation and sedation will be progressively modified according to the LDPV algorithm to achieve targets. Patients will be crossed-over to the opposite PEEP strategy. LDPV titration will then be repeated to achieve LDPV targets. After establishing a combination of ventilation and sedation settings at which LDPV targets are achieved, the targets will be maintained over a 24-hour period.

Timeline

Start date
2019-02-01
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2018-08-02
Last updated
2024-12-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03612583. Inclusion in this directory is not an endorsement.

Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work (NCT03612583) · Clinical Trials Directory